Subject to TSX Venture Exchange (“ TSXV ”) approval, NurExone has engaged Russo Partners LLC, a New York–based strategic ...
NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company"), a preclinical-biotechnology ...
Cancer remains the leading driver of healthcare costs for employers, with a significant rise in cases among people under 50. 1, 2 MSK Direct addresses this challenge, helping benefits leaders ...
Amanda has written in the personal finance space for several years and previously worked as a risk analyst at a local community bank. She researches economics, emerging financial trends and the future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback